Subjects with coronary heart disease (CHD) had significantly lower levels of SFRP5 than non-CHD controls, and the serum level of SFRP5 was negatively associated with the severity of CHD (Miyoshi et al., 2014). Here, SFRP5 is linked to coronary artery disorder.